Femasys (FEMY) Competitors $0.95 +0.01 (+1.32%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$0.94 -0.01 (-1.03%) As of 07/2/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FEMY vs. SRTS, NSPR, APYX, ZYXI, VANI, CTSO, INO, TELA, EDAP, and MLSSShould you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Sensus Healthcare (SRTS), InspireMD (NSPR), Apyx Medical (APYX), Zynex (ZYXI), Vivani Medical (VANI), Cytosorbents (CTSO), Inovio Pharmaceuticals (INO), TELA Bio (TELA), Edap Tms (EDAP), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry. Femasys vs. Its Competitors Sensus Healthcare InspireMD Apyx Medical Zynex Vivani Medical Cytosorbents Inovio Pharmaceuticals TELA Bio Edap Tms Milestone Scientific Sensus Healthcare (NASDAQ:SRTS) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends. Does the media refer more to SRTS or FEMY? In the previous week, Femasys had 2 more articles in the media than Sensus Healthcare. MarketBeat recorded 4 mentions for Femasys and 2 mentions for Sensus Healthcare. Femasys' average media sentiment score of 0.77 beat Sensus Healthcare's score of 0.58 indicating that Femasys is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sensus Healthcare 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Femasys 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, SRTS or FEMY? Sensus Healthcare has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Femasys has a beta of -2.56, suggesting that its share price is 356% less volatile than the S&P 500. Which has stronger earnings & valuation, SRTS or FEMY? Sensus Healthcare has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M1.85$6.65M$0.1047.00Femasys$1.63M14.89-$18.82M-$0.91-1.04 Do insiders & institutionals have more ownership in SRTS or FEMY? 25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by company insiders. Comparatively, 11.5% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer SRTS or FEMY? Sensus Healthcare presently has a consensus price target of $11.67, suggesting a potential upside of 148.23%. Femasys has a consensus price target of $8.67, suggesting a potential upside of 812.47%. Given Femasys' higher possible upside, analysts plainly believe Femasys is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Femasys 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SRTS or FEMY more profitable? Sensus Healthcare has a net margin of 4.56% compared to Femasys' net margin of -1,242.06%. Sensus Healthcare's return on equity of 3.34% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare4.56% 3.34% 3.00% Femasys -1,242.06%-392.45%-137.15% SummarySensus Healthcare beats Femasys on 10 of the 16 factors compared between the two stocks. Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FEMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FEMY vs. The Competition Export to ExcelMetricFemasysMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.95M$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E Ratio-1.0421.3126.1719.90Price / Sales14.89278.47413.55113.66Price / CashN/A41.4736.1356.90Price / Book9.507.518.025.38Net Income-$18.82M-$55.05M$3.15B$248.50M7 Day Performance-3.40%2.07%1.48%2.06%1 Month Performance18.73%4.84%3.66%4.86%1 Year Performance-13.65%5.37%34.68%20.24% Femasys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FEMYFemasys3.7148 of 5 stars$0.95+1.3%$8.67+812.5%-14.4%$23.95M$1.63M-1.0430Gap UpSRTSSensus Healthcare1.8771 of 5 stars$4.60-2.7%$11.67+153.6%-4.7%$77.79M$41.81M46.0040NSPRInspireMD3.0542 of 5 stars$2.52+2.4%$4.50+78.6%-5.5%$77.20M$7.03M-3.3650APYXApyx Medical2.2589 of 5 stars$2.00flatN/A+60.4%$75.59M$48.10M-3.64270Positive NewsGap DownZYXIZynex2.6248 of 5 stars$2.39-4.0%$6.00+151.0%-70.3%$75.29M$192.35M-9.96770News CoverageAnalyst ForecastVANIVivani Medical3.3238 of 5 stars$1.26flat$4.00+217.5%+5.0%$74.65MN/A-2.9320High Trading VolumeCTSOCytosorbents1.8095 of 5 stars$1.26+6.8%$5.50+336.5%+21.7%$73.88M$35.60M-4.50220News CoverageGap DownINOInovio Pharmaceuticals3.6675 of 5 stars$1.93-1.5%$9.75+405.2%-74.6%$71.88M$220K-0.61320News CoverageTELATELA Bio3.3186 of 5 stars$1.73+4.8%$7.25+319.1%-58.6%$65.27M$71.22M-1.23120EDAPEdap Tms2.9283 of 5 stars$1.72+1.3%$8.50+394.2%-70.4%$63.49M$69.18M-2.77230MLSSMilestone Scientific2.6913 of 5 stars$0.80-9.1%$1.25+56.4%-3.7%$62.70M$8.61M-11.4130Gap Down Related Companies and Tools Related Companies Sensus Healthcare Alternatives InspireMD Alternatives Apyx Medical Alternatives Zynex Alternatives Vivani Medical Alternatives Cytosorbents Alternatives Inovio Pharmaceuticals Alternatives TELA Bio Alternatives Edap Tms Alternatives Milestone Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FEMY) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FEMY Stock Alerts